Novanta Inc.
NASDAQ:NOVTHardware, Equipment & Parts
+$3.35 today
- Market cap
- $4.46B
- Beta
- 1.68
- P/E (TTM)
- 116.5
- EPS (TTM)
- $1.33
Volume 0.46M
Average 0.44M
NOVT Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Novanta Inc.NASDAQ: NOVT
Research & Development · Q3 FY2026 · quarter ended Oct 2026
Research & development growth accelerates
Q3 FY2026 research & development of $26.35M rose 9.4% year over year, ahead of the -1.5% change in trailing-twelve-month research & development. Sequentially, it rose 9.9% from the prior quarter. Over 3 fiscal years it compounded at +3.6% a year.
Context
- Research & development amounted to 9.7% of revenue in FY2025, down 0.3 pp from a year earlier.
- Research & development increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +9.4% holds above the trailing-twelve-month pace of -1.5%.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 95.48M USD
- Year-over-year change
- -0.0%
- 4-year CAGR
- +7.1%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 95.48M | -0.0% |
| FY2024 | 2024-12-31 | 95.52M | +4.2% |
| FY2023 | 2023-12-31 | 91.68M | +6.9% |
| FY2022 | 2022-12-31 | 85.77M | +18.3% |
| FY2021 | 2021-12-31 | 72.52M | — |
Research & Development vs competitors
How NOVT compares with its peers on the latest reported figures
- NOVT's LTM Oct 2026 research & development of $96.43M is the 6th highest of the 11 companies compared; the peer median is $63.58M.
- Its year-over-year change of -1.5% is the 7th highest of 8, against a peer median of +11.0%.
- Research & development amounts to 8.9% of revenue for NOVT, versus a peer median of 5.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $722.97M | +24.2% | +13.1% | 10.2% | |
| LTM Sep 2026 | $330.6M | +37.7% | -3.4% | 5.1% | |
| LTM Jun 2026 | $311M | +10.7% | +7.5% | 7.2% | |
| LTM Oct 2026 | $139.37M | +2.9% | -0.5% | 12.4% | |
| LTM Jun 2026 | $123.44M | +11.0% | +0.4% | 11.5% | |
| LTM Oct 2026 | $96.43M | -1.5% | +3.6% | 8.9% | |
| LTM Mar 2026 | $3.72M | +44.2% | +13.7% | 5.9% | |
| LTM Mar 2026 | $1.06M | -17.7% | +20.2% | 3.7% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Apr 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding NOVT) | $63.58M | +11.0% | +7.5% | 5.5% | |
Competitors are the stored peer set for NOVT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 706.79M | 860.9M | 881.66M | 949.25M | 980.6M |
| Cost of Revenue | 406.47M | 482.43M | 481.77M | 527.7M | 572.79M |
| Gross Profit | 300.33M | 378.47M | 399.9M | 421.55M | 407.81M |
| Gross Margin | 42.5% | 44.0% | 45.4% | 44.4% | 41.6% |
| Research & Development | 72.52M | 85.77M | 91.68M | 95.52M | 95.48M |
| Selling, General & Admin | 129.16M | 158.9M | 164.46M | 175.94M | 195.66M |
| Operating Expenses | 236.27M | 275.39M | 289.4M | 310.96M | 291.14M |
| Depreciation & Amortization | 43.39M | 53.16M | 46.61M | 55.56M | 61.93M |
| EBITDA | 125.47M | 160.62M | 169.92M | 179.86M | 153.05M |
| EBITDA Margin | 17.8% | 18.7% | 19.3% | 18.9% | 15.6% |
| Operating Income | 64.05M | 103.08M | 110.5M | 110.58M | 116.66M |
| Operating Margin | 9.1% | 12.0% | 12.5% | 11.6% | 11.9% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 7.39M | 15.62M | 25.82M | 31.49M | 21.47M |
| Other Income / Expenses | (7.88M) | (15.92M) | (26.75M) | (31.52M) | (47.02M) |
| Income Before Tax | 56.17M | 87.16M | 83.75M | 79.07M | 69.64M |
| Pre-Tax Margin | 7.9% | 10.1% | 9.5% | 8.3% | 7.1% |
| Income Tax Expense | 5.84M | 13.11M | 10.87M | 14.98M | 15.81M |
| Net Income | 50.33M | 74.05M | 72.88M | 64.09M | 53.83M |
| Net Margin | 7.1% | 8.6% | 8.3% | 6.8% | 5.5% |
| EPS (Basic) | 1.42 | 2.08 | 2.03 | 1.78 | 1.47 |
| EPS (Diluted) | 1.41 | 2.06 | 2.02 | 1.77 | 1.47 |
| Weighted Avg Shares | 35.4M | 35.65M | 35.84M | 35.95M | 36.59M |
| Weighted Avg Shares (Diluted) | 35.78M | 35.91M | 36.03M | 36.12M | 36.7M |
Novanta Inc.
NASDAQ:NOVT
Intrinsic Alpha fair value
Locked
Current Price
$117.89
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.